Advances in pharmacotherapy for the treatment of allergic rhinitis; MP29-02 (a novel formulation of azelastine hydrochloride and fluticasone propionate in an advanced delivery system) fills the gaps

Expert Opinion on Pharmacotherapy
Jean BousquetUlrich Wahn

Abstract

Effective pharmacologic treatment exists for most patients suffering from allergic rhinitis (AR). However, both in clinical trials and in real-life studies, many patients are dissatisfied with treatment. Physicians often use multiple therapies, in an attempt to improve symptom control, often with limited evidence of success. Novel treatment options are needed and must consider unmet medical needs. This article reviews the clinical data for a new AR treatment. MP29-02 (Dymista®, Meda, Solna, Sweden) contains azelastine hydrochloride (AZE) and fluticasone propionate (FP), in a novel formulation and delivered in an improved device as a single nasal spray. It has shown superior efficacy in AR patients than either commercially available AZE or FP monotherapy for both nasal and ocular symptom relief, regardless of disease severity. MP29-02 also provided more effective and rapid symptom relief than either AZE or FP monotherapy delivered in the MP29-02 formulation and device. However, the effect was less than that observed versus commercial comparators, suggesting the impact of formulation and device on clinical efficacy. MP29-02 simplifies AR management, surpassing the efficacy of gold standard treatment, intranasal corticosteroids (I...Continue Reading

References

Jan 1, 1989·The Journal of Allergy and Clinical Immunology·G D'Amato, G Lobefalo
May 1, 1987·The Journal of Allergy and Clinical Immunology·T A Platts-MillsS R Wilkins
Nov 14, 1997·Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology·M MandlB N Lutsky
Aug 19, 1999·The Journal of Allergy and Clinical Immunology·E F JuniperJ N Roberts
Sep 10, 1999·Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology·H MilgromC C Wood
Nov 15, 2001·The Journal of Allergy and Clinical Immunology·J BousquetUNKNOWN World Health Organization
Feb 20, 2003·The Journal of Allergy and Clinical Immunology·Mark S Dykewicz
Jul 16, 2003·Allergy·J BousquetP Demoly
Jul 26, 2005·The Journal of Biological Chemistry·Valia A VerrièreValérie Urbach
Jan 3, 2006·The Journal of Allergy and Clinical Immunology·Jean BousquetBashar Allaf
Aug 29, 2006·Lancet·Sally E Wenzel
Feb 15, 2007·Allergy·J BousquetA Sheffer
Aug 29, 2007·Current Medical Research and Opinion·Jonathan A Bernstein
Dec 6, 2007·Allergy·G W CanonicaJ C Virchow
Dec 18, 2007·Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology·G K ScaddingUNKNOWN British Society for Allergy and Clinical Immunology
Jan 22, 2008·The Journal of Allergy and Clinical Immunology·Allan R BrasierWilliam J Calhoun
Apr 23, 2008·Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology·Robert Anolik, UNKNOWN Mometasone Furoate Nasal Spray With Loratadine Study Group
Jul 31, 2008·The Journal of Allergy and Clinical Immunology·Dana V WallaceUNKNOWN Joint Council of Allergy, Asthma and Immunology
Feb 24, 2009·Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology·Friedrich HorakMelvyn Danzig
Jun 23, 2009·Respiratory Medicine·Karen G SchueeppJohannes H Wildhaber
Aug 8, 2009·The Journal of Allergy and Clinical Immunology·Jean BousquetUNKNOWN Extended Global Allergy and Asthma European Network, World Allergy Organization and Allergic Rhinitis and its Impact on Asth
Mar 10, 2010·Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology·M VargheseR F Lockey
Mar 24, 2010·Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology·Michael SchatzMark Kosinski
Apr 29, 2010·Current Allergy and Asthma Reports·Peter W Hellings, Emmanuel P Prokopakis
Jun 24, 2010·Primary Care Respiratory Journal : Journal of the General Practice Airways Group·David PriceGokul Gopalan
Aug 3, 2010·Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology·Rania EsteitieFuad M Baroody
Aug 3, 2010·Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology·Frank C HampelHarry Sacks
Sep 8, 2010·The Journal of Allergy and Clinical Immunology·Jan L BrozekUNKNOWN Grading of Recommendations Assessment, Development and Evaluation Working Group
Oct 12, 2010·The Journal of Allergy and Clinical Immunology·Maurizio MarognaGiovanni Passalacqua
Jan 26, 2011·Pediatric Allergy and Immunology : Official Publication of the European Society of Pediatric Allergy and Immunology·Ignacio JáureguiAntonio Valero
Mar 16, 2011·Current Medical Research and Opinion·Giorgio CiprandiOliviero Rossi

❮ Previous
Next ❯

Citations

Jan 7, 2016·Expert Opinion on Emerging Drugs·Amelia LicariGiorgio Ciprandi
Mar 2, 2016·Pediatric Allergy and Immunology : Official Publication of the European Society of Pediatric Allergy and Immunology·Ulrich Wahn
Jan 23, 2016·Expert Opinion on Pharmacotherapy·Ludger KlimekWytske Fokkens
Apr 17, 2016·Immunology and Allergy Clinics of North America·Pavol Surda, Wytske J Fokkens
Apr 17, 2016·Immunology and Allergy Clinics of North America·David I BernsteinJonathan A Bernstein
Feb 4, 2016·Expert Review of Clinical Pharmacology·Ludger KlimekDavid Price
May 14, 2016·Expert Review of Clinical Pharmacology·E RidoloG Senna
Jan 27, 2017·American Journal of Rhinology & Allergy·Justin C Greiwe, Jonathan A Bernstein
Aug 31, 2018·Journal of Applied Physiology·Julia LitvinovBill T Ameredes
May 21, 2020·Pharmacy : Journal of Pharmacy, Education and Practice·Olga LourençoJean Bousquet
Apr 25, 2019·Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology·Leif BjermerMagnus C Wickman
Dec 21, 2019·Pharmacology Research & Perspectives·Carlos D Zappia, Federico Monczor
Sep 19, 2017·Expert Review of Respiratory Medicine·Amelia LicariGian Luigi Marseglia
Sep 2, 2017·Expert Review of Respiratory Medicine·Todor A PopovMartin Church

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allergy and Asthma

Allergy and asthma are inflammatory disorders that are triggered by the activation of an allergen-specific regulatory t cell. These t cells become activated when allergens are recognized by allergen-presenting cells. Here is the latest research on allergy and asthma.